Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...

June 10, 2024 | Monday | News
Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to...

April 05, 2024 | Friday | News
BiomX Acquires Adaptive Phage Therapeutics, Secures $50M for Clinical Trials

  Immediately after the effective time of the Acquisition, and before giving effect to the concurrent private placement the former stockholders of Bi...

March 06, 2024 | Wednesday | News
Wegovy Producer Catalent Snapped Up in $16.5 Billion Deal by Novo Holdings

In a strategic shift that promises to redefine the pharmaceutical industry, Novo Holdings, the investment arm of Novo Nordisk's parent foundation, has unve...

February 05, 2024 | Monday | News
Alto's Brainy Bonanza: Neuroscience Powerhouse ANRO Unleashes $128.6M IPO Surge

In a move that adds an intriguing layer to the IPO dynamics, Alto has granted underwriters a 30-day option to scoop up an additional 1,206,000 shares of co...

February 02, 2024 | Friday | News
Bristol Myers Squibb Acquires Mirati Therapeutics, Bolstering Oncology Portfolio

“The closing of the Mirati transaction is a significant milestone in our efforts to further diversify our oncology portfolio and strengthen our pipel...

January 23, 2024 | Tuesday | News
Pfizer Urges Shareholders to Decline TRC Capital's Below-Market Mini-Tender Offer

Pfizer does not endorse TRC Capital Investment’s unsolicited mini-tender offer and recommends that stockholders do not tender their shares in respons...

January 11, 2024 | Thursday | News
QIAGEN Unleashes a Thrilling Windfall: Proposes a Whopping $300 Million Bonanza for Shareholders!

QIAGEN  announced a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repurchase tha...

January 08, 2024 | Monday | News
Standard BioTools Stockholders Approve Merger with SomaLogic

“We are pleased with the outcome of today’s Special Meeting and thank our stockholders for their support for this merger,” said Michael E...

January 05, 2024 | Friday | News
Citius Pharmaceuticals, Guided by CEO Leonard Mazur, Charts a Promising Course for 2024 with Pipeline Success and Strategic Moves

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercial...

January 03, 2024 | Wednesday | News
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, O...

December 04, 2023 | Monday | News
Syncona to Acquire Freeline Therapeutics

Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial pro...

November 23, 2023 | Thursday | News
Inari Medical Closes Acquisition of LimFlow

“The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients suffering from C...

November 16, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in